We live in a golden age of medical science, but is the policy ready?
It took 13 years to sequence the first human genome; today, hundreds can be read in hours.
License in Applied Economics from the Université Catholique de Louvain (UCL) and an MBA from the Katholieke Universiteit Leuven (KUL) in Belgium. Formerly: Continental Illinois Bank of Chicago; 18 years with Dow Chemical Co., Belgium, France, US and Switzerland. 2002-05, Chief Financial Officer, Europe, Baxter International. With ABB: 2005-13, Executive VP, and Chief Financial Officer; 2008, interim Chief Executive Officer and 2008 - March 2011, President, Global Markets. Vice-Chairman of the Board, UBS AG; Chairman of the Board, Syngenta AG . Member of the Supervisory Board, Louis-Dreyfus Company Int'l Holding B.V., Rotterdam. Chairman of the Foundation and Supervisory Boards, IMD Business School, Lausanne. Board member Vodafone Group Plc and Chairman Nomoko AG
It took 13 years to sequence the first human genome; today, hundreds can be read in hours.
Last year was one of great political change and now today’s government leaders hold tomorrow in their hands. To deliver sustainable growth and build a better future for people, society an...
El año pasado fue de grandes cambios electorales; ahora, los gobernantes de hoy tienen el mañana en sus manos. Para lograr un crecimiento sostenible y construir un futuro mejor para las p...
We're entering a new era of science and innovation that has the potential to revolutionize how healthcare is designed, developed and delivered. Thanks to digital innovation, data and arti...


